Literature DB >> 434983

Procainamide-induced agranulocytosis and thrombocytopenia.

I K Rothman, E L Amorosi.   

Abstract

Procainamide therapy has frequently been reported as a cause of agranulocytosis, but severe thrombocytopenia associated with the use of this drug has been noted only once. We report a case of simultaneously occurring agranulocytosis and profound thrombocytopenia in a patient receiving procainamide hydrochloride. Different mechanisms appeared to be responsible for the two cytopenias.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 434983

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  3 in total

1.  Transient pancytopenia. A report from the International Agranulocytosis and Aplastic Study.

Authors:  M Keisu; W Heit; G Lambertenghi-Deliliers; J Parcells-Kelly; A Polliack; H Heimpel
Journal:  Blut       Date:  1990-10

Review 2.  Adverse effects of antiarrhythmic drugs.

Authors:  J B Schwartz; D Keefe; D C Harrison
Journal:  Drugs       Date:  1981-01       Impact factor: 9.546

3.  Modulation of procainamide toxicity by selenium-enriched yeast in rats.

Authors:  M Toborek; K Magner-Wróbel; M Drózdz; A Danch; E Kopieczna-Grzebieniak
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.